Quantitative Study of Seven Chemical Constituents in the Aqueous Concentrate of Yuxingcao Qinlan Mixture Based on the Analytical Quality by Design Concept
Scientific Papers|更新时间:2024-11-26
|
Quantitative Study of Seven Chemical Constituents in the Aqueous Concentrate of Yuxingcao Qinlan Mixture Based on the Analytical Quality by Design Concept
Journal of Instrumental AnalysisVol. 43, Issue 11, Pages: 1687-1696(2024)
TIAN Tian,WANG Xin-yu,NIE Fu-li,LI Jin-hao,WANG Juan,GONG Xing-chu.Quantitative Study of Seven Chemical Constituents in the Aqueous Concentrate of Yuxingcao Qinlan Mixture Based on the Analytical Quality by Design Concept[J].Journal of Instrumental Analysis,2024,43(11):1687-1696.
TIAN Tian,WANG Xin-yu,NIE Fu-li,LI Jin-hao,WANG Juan,GONG Xing-chu.Quantitative Study of Seven Chemical Constituents in the Aqueous Concentrate of Yuxingcao Qinlan Mixture Based on the Analytical Quality by Design Concept[J].Journal of Instrumental Analysis,2024,43(11):1687-1696. DOI: 10.12452/j.fxcsxb.240729257.
Quantitative Study of Seven Chemical Constituents in the Aqueous Concentrate of Yuxingcao Qinlan Mixture Based on the Analytical Quality by Design Concept
A high performance liquid chromatography(HPLC) method for the determination of chlorogenic acid,cryptochlorogenic acid,quercitrin,baicalin,wogonoside,baicalein and wogonin in the aqueous concentrate of Yuxingcao Qinlan Mixture was established based on the analytical quality by design(AQbD) concept. An Ishikawa diagram was employed to find all method parameters. A definitive screening design was used to clarify the critical method attributes(CMAs). CMAs were the resolution between quercitrin and the adjacent peak,and the retention time of the last peak. The weighted determination coefficient method was utilized to find the critical method parameters(CMPs),which were the end time of the first gradient,the end time of the third gradient,the end time of the fourth gradient,column temperature and flow r
ate. Quantitative models between these CMPs and CMAs were then established using a stepwise regression method,with model
R
2
values exceeding 0.90. The non-compliance probability values were utilized to quantitatively characterize the risk level associated with different parameter combinations. Based on the risk assessment,the method operable design region(MODR) was identified and its reliability was successfully validated. The separation was achieved with a Sunshell-C
18
(150 mm×4.6 mm,2.6 μm) column at 39.0 ℃,using 0.60% formic acid in water(A) and acetonitrile(B) as the mobile phases in gradient elution at a flow rate of 0.80 mL/min. The elution was monitored at UV detection wavelengths of 260 nm and 326 nm. The injection volume was 10 μL.The optimized method was also validated. The results showed excellent linear regression,with the relative standard deviation(RSD) values for accuracy,precision,stability,and repeatability all less than 5.0%.All recoveries of the 7 compounds ranged from 92.6% to106%,with the RSD values of less than 2.0%.
关键词
分析质量源于设计高效液相色谱法鱼腥草芩蓝合剂水提浓缩液确定性筛选设计方法可操作设计区域
Keywords
analytical quality by designhigh performance liquid chromatography(HPLC)aqueous concentrate of Yuxingcao Qinlan Mixturedefinitive screening designmethod operable design region
references
Wen H,Zheng Z Y,Zhang J,Wang J,Chen C C,Wang H Y,Shi M J,Chen Y,Tao Y,Zheng M. Asia-Pac. Tradit. Med.(温浩,郑致远,张杰,汪娟,陈橙晨,王欢莹,石梦军,陈郁,陶益,郑猛. 亚太传统医药),2024,20(4):20-26.
Song P J,Wu X H,Zhang S D,Wang D S,Yang J,Li Y J,Shao D,Shen W X,Jiang W,Yan Z T. Acta Agric. Boreali-Occident. Sin.(宋朋杰,武小虎,张世栋,王东升,杨洁,李亚娟,邵丹,沈文祥,蒋威,严作廷. 西北农业学报),2020,29(2):165-174.
Liang R. Chin. Foreign Med. Res.(梁锐. 中外医学研究),2024,22(4):42-45.
Zhao H Q. Chin. Foreign Med. Res.(赵惠琴. 中外医学研究),2021,19(4):33-36.
Deng M F,Cheng W M. Chin. J. Mod. Appl. Pharm.(邓茂芳,程维明. 中国现代应用药学),2015,32(5):589-591.
Cui X T,Wang Y X,Wen H,Chen C C,Zhang J,Chen Y. Tianjin Chem. Ind.(崔晓甜,汪叶昕,温浩,陈橙晨,张杰,陈郁. 天津化工),2024,38(3):54-59.
Zhejiang Huisong Pharmaceutical Co.,LTD. China Patent(浙江惠松制药有限公司. 中国专利),202211016858.8. 2022-11-22.
Musters J,van den Bos L,Kellenbach E. Org. Process Res. Dev.,2013,17(1):87-96.
Tome T,Zigart N,Casar Z,Obreza A. Org. Process Res. Dev.,2019,23(9):1784-1802.
Jiang S H,Dai S Y,Zheng J,Ma S C,Zhou J. Chin. Pharm. J.(蒋双慧,戴胜云,郑健,马双成,周娟. 中国药学杂志),2022,57(13):1122-1130.
Ding F,Liu S H,Wu G L,Qu H B,Gong P,Xie Y J,Zhou P,Gong X C. Microchem. J.,2023,194:109253.
Lan J,Wu G L,Wu L L,Qu H B,Gong P,Xie Y J,Zhou P,Gong X C. Separations,2023,10(1):13.
Tai Y N,Ren D D,Zhao W S,Qu H B,Xiong H S,Gong X C. Microchem. J.,2023,187:108438.
Tai Y N,Zhao M T,Ding F,Wu G L,Qu H B,Gong P,Xie Y J,Zhou P,Gong X C. Phytochem. Anal.,2024,35(5):1088-1099.
Dharuman N,Lakshmi K S,Krishnan M. Green Chem. Lett. Rev.,2023,16(1):2214176.
Peraman R,Bandi J,Kondreddy V K,Kalva B,Kothakota S G,Paritala J,Nagappan K,Yirgamreddy P R. J. Liq. Chromatogr. Relat. Technol.,2021,44(3/4):197-209.
Shirkhedkar A A,Chaudhari S R. Biomed. Chromatogr.,2022,36(1):e5244.
Harish V,Almalki W H,Alshehri A,Alzahrani A,Gupta M M,Alzarea S I,Kazmi I,Gulati M,Tewari D,Gupta G,Dua K,Singh S K. Molecules,2023,28(2):472.
Teng J H,Zhu C M,Lyu J Y,Pan L Y,Zhang M,Zhang F L,Wu H X. J. Pharm. Biomed. Anal.,2022,207:114417.
Chiow K H,Phoon M C,Putti T,Tan B K H,Chow V T. Asian Pac. J. Trop. Med.,2016,9(1):1-7.
Shingnaisui K,Dey T,Manna P,Kalita J. J. Ethnopharmacol.,2018,220:35-43.
Ding J X,Liu C,Liu X W,Yan W N,Li W P,Shi H,Li J X,Tang C L,Zhou Y. Exp. Ther. Med.,2021,22(1):665.
Chang Y L,Huang K,Yang F,Gao Y Y,Zhang Y,Li S,Liu B,Guo S Z. J. Funct. Foods,2022,96:105216.
Tang G Y,Li S,Xu Y,Zhang C,Xu X Y,Xu L,Wang N,Feng Y B. Phytomedicine,2023,116:154812.
Zhang M M,Zhao Z G,Liu Q,Liu W,Wang X,Zhao H Q. Chin. Tradit. Herb. Drugs(张敏敏,赵志国,刘倩,刘伟,王晓,赵恒强. 中草药),2021,52(11):3193-3200.
Zhao T T,Tang H L,Xie L,Zheng Y,Ma Z B,Sun Q,Li X F. J. Pharm. Pharmacol.,2019,71(9):1353-1369.
Chanaj-Kaczmarek J,Rosiak N,Szymanowska D,Rajewski M,Wender-Ozegowska E,Cielecka-Piontek J. Pharmaceutics,2022,14(4):740.
Sun M F,Yang J F,Cao W,Shao J F,Wang G X,Qu H B,Huang W H,Gong X C. Chin. Herb. Med.,2020,12(2):125-132.
Shao J Y,Qu H B,Gong X C. China J. Chin. Mater. Med. (邵静媛,瞿海斌,龚行楚. 中国中药杂志),2018,43(10):2074-2080.
Chen B,Wang X Y,Ai Y T,Jiang J P,Gong X C. Chin. Tradit. Herb. Drugs(陈博,王欣雨,艾玉廷,蒋剑平,龚行楚. 中草药),2024,55(17):5822-5831.
Q14final version). Analytical Procedure Development. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
WS3-1072(Z-274)-2007Z-2011.Yuxingcao Qinlan Heji. National Standards of the People's Republic of China(鱼腥草芩蓝合剂. 中华人民共和国国家标准).